HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christian Berthou Selected Research

PMitCEBO protocol

12/2021Prognostic value of interim FDG PET-CT in patients older than 60 years with diffuse large B-cell lymphoma treated by PMitCEBO plus rituximab. Comparison between Deauville 5-point scale and International Harmonization Project criteria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christian Berthou Research Topics

Disease

18B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2022 - 03/2005
16Neoplasms (Cancer)
04/2020 - 03/2004
12Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020 - 08/2003
11Lymphoma (Lymphomas)
01/2018 - 03/2004
10BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
07/2015 - 04/2003
8Multiple Myeloma
10/2020 - 01/2002
8Hodgkin Disease (Hodgkin's Disease)
01/2013 - 01/2004
6Neutropenia
10/2020 - 08/2013
5Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2016 - 06/2003
5Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2012 - 06/2005
4Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2017 - 06/2007
4Primary Myelofibrosis (Myelosclerosis)
11/2017 - 08/2006
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2021 - 10/2010
3Infections
10/2020 - 01/2018
3Autoimmune Diseases (Autoimmune Disease)
04/2020 - 06/2005
3Leukemia
01/2019 - 12/2010
3Polycythemia Vera
01/2018 - 05/2008
3B-Cell Lymphoma (Lymphoma, B Cell)
01/2018 - 04/2011
3Essential Thrombocythemia
01/2018 - 04/2006
3Pathologic Complete Response
02/2017 - 08/2003
2Thrombocytopenia (Thrombopenia)
10/2020 - 01/2017
2Febrile Neutropenia
01/2018 - 11/2013
2Rheumatoid Arthritis
08/2013 - 02/2008
2Sleepiness
03/2012 - 08/2006
2Peripheral Nervous System Diseases (PNS Diseases)
03/2012 - 11/2011
2Intraocular Lymphoma
09/2011 - 11/2008
1Progressive Multifocal Leukoencephalopathy
10/2020
1Hereditary Complement Deficiency Diseases
04/2020
1Hematologic Neoplasms (Hematological Malignancy)
04/2020
1Aspergillosis
01/2020
1Colitis
01/2019
1Thrombosis (Thrombus)
01/2018
1Fever of Unknown Origin
01/2018
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
11/2017
1Venous Thromboembolism
03/2017
1Aplastic Anemia (Anemia, Hypoplastic)
02/2017
1Body Weight (Weight, Body)
02/2017
1Philadelphia Chromosome
11/2016

Drug/Important Bio-Agent (IBA)

14Rituximab (Mabthera)FDA Link
12/2021 - 02/2008
11Imatinib Mesylate (Gleevec)FDA Link
11/2016 - 04/2003
8Cytarabine (Cytosar-U)FDA LinkGeneric
02/2017 - 04/2003
7Monoclonal AntibodiesIBA
04/2020 - 04/2007
6Thalidomide (Thalomid)FDA Link
10/2020 - 01/2002
6Doxorubicin (Adriamycin)FDA LinkGeneric
01/2013 - 01/2004
5Bleomycin (Blenoxane)FDA LinkGeneric
01/2013 - 01/2004
5Dacarbazine (DIC)FDA LinkGeneric
01/2013 - 01/2004
5Vinblastine (Vinblastine Sulfate)FDA Link
01/2013 - 01/2004
3Biological ProductsIBA
01/2022 - 04/2011
3Pharmaceutical PreparationsIBA
01/2018 - 08/2013
3Methotrexate (Mexate)FDA LinkGeneric
02/2017 - 01/2004
3Member 1 Subfamily B ATP Binding Cassette TransporterIBA
02/2012 - 08/2003
2Dexamethasone (Maxidex)FDA LinkGeneric
10/2020 - 11/2011
2Lenalidomide (CC 5013)FDA Link
10/2020 - 09/2009
2Bortezomib (Velcade)FDA Link
10/2020 - 11/2011
2Complement System Proteins (Complement)IBA
04/2020 - 01/2014
2AnticoagulantsIBA
01/2018 - 10/2017
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2018 - 10/2017
2Lomustine (CCNU)FDA Link
02/2017 - 06/2010
2Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
02/2017 - 06/2010
2Cyclin-Dependent Kinases (cdk Proteins)IBA
07/2015 - 05/2013
2PlatinumIBA
01/2015 - 09/2011
2Filgrastim (Neupogen)FDA Link
01/2014 - 11/2013
2Biosimilar PharmaceuticalsIBA
01/2014 - 11/2013
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
04/2011 - 06/2003
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
06/2010 - 11/2009
2Melphalan (Alkeran)FDA LinkGeneric
06/2008 - 02/2002
2AnthracyclinesIBA
02/2008 - 11/2004
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2003 - 04/2003
2bcr-abl Fusion ProteinsIBA
12/2003 - 04/2003
1ZincIBA
01/2022
1LigandsIBA
01/2022
1brincidofovirIBA
10/2020
1Antiviral Agents (Antivirals)IBA
10/2020
1posaconazoleFDA Link
01/2020
1idelalisibIBA
01/2019
1CalciumIBA
01/2019
1Dihydrotachysterol (AT 10)IBA
01/2019
1Vitamin KFDA Link
01/2018
1Anti-Bacterial Agents (Antibiotics)IBA
01/2018
1Proteins (Proteins, Gene)FDA Link
11/2017
1CytosineIBA
09/2017
1CalreticulinIBA
03/2017
1Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric
02/2017
1AndrogensIBA
02/2017
1NorethandroloneIBA
02/2017
11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2017
1Asparaginase (Elspar)FDA Link
11/2016
1Dasatinib (BMS 354825)FDA Link
11/2016
1Complement C4 (Complement Component 4)IBA
03/2016

Therapy/Procedure

25Therapeutics
10/2020 - 01/2002
18Drug Therapy (Chemotherapy)
01/2019 - 06/2003
11Stem Cell Transplantation
01/2018 - 02/2002
4Radiotherapy
01/2018 - 01/2004
4Transplantation
01/2017 - 03/2004
3Aftercare (After-Treatment)
04/2020 - 04/2006
3Bone Marrow Transplantation (Transplantation, Bone Marrow)
12/2010 - 11/2004
2Induction Chemotherapy
01/2017 - 12/2007
2Injections
04/2011 - 11/2008
1PMitCEBO protocol
12/2021
1Radioimmunotherapy
01/2017